David Fallace

Verified

Managing Partner at Cure Ventures ManagementListed on SEC Form ADVBoston, United States

Claim this profile

Warm

Check Size

Not yet known

Reliability Score

🎯100% of deals in Healthcare

Investment Timeline

Tasca Therapeutics

Board seat (SEC Form D)Source

Since Nov 2024

Company last raised Dec 2025

Portfolio Breakdown

By Sector

Healthcare1 deal · 100%

By Stage

1 tracked deal1 sector · 0 stages

Deal Velocity

Avg Deals / Year

1.0

Avg Deal Size

Unknown

Largest Deal

Tasca Therapeutics

Unknown

YoY Trend

Steady

Deals Per Year

1 total deal tracked2024–2024

Investment Activity Map

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

2024

Less

Current Fund Status

Fund Name

Cure Ventures Fund I, L.P.

Reported Size

$360.8M

Co-Investors

No co-investment data available yet.